Fibrosis is a condition of the liver caused by certain diseases and conditions which can progress through several stages culminating in cirrhosis where it becomes non-reversible. Fibrosis is typically diagnosed by an invasive liver biopsy and staging the increasing severity of the fibrosis is important for a physician to monitor so treatment changes can be implemented. Fibrosis staging can be made through repeated biopsies which can be dangerous and very expensive.

There are several laboratory tests used to assess liver function. Of all the non-invasive laboratory tests available, Hyaluronic Acid (HA) is now considered the most sensitive marker to assess liver fibrosis.

Corgenix has developed several diagnostic products which measure Hyaluronic Acid (HA): a manual version released in 1997 and an automated version released in 2011.

Learn more about our Non-Invasive Liver Biomarker Products by visiting www.corgenixonline.com.